Inspiremd announces appointment of michael lawless as chief financial officer

Miami, june 03, 2025 (globe newswire) -- inspiremd, inc. (nasdaq: nspr), developer of the cguard™ prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced the appointment of michael lawless, an industry veteran, as chief financial officer, effective on or prior to june 30, 2025 (the “effective date”). on the effective date, mr.
NSPR Ratings Summary
NSPR Quant Ranking